Adtran stock plunges nearly 16% as Q2 revenue, margin guidance disappoints
ADTRAN Inc (ADTN) plunged 15.82% after the company released preliminary unaudited second-quarter results well below prior guidance and market expectations. The scale of the drop is reinforced by broad selling pressure, as Adtran remains below all key moving averages and signals for both momentum and oscillators remain negative, with some oversold signs limiting further downside.
Highlights
- Adtran's Q2 preliminary revenue of $280–$282 million and non-GAAP operating margin of 3.5–4% both fell short of prior guidance and consensus expectations.
- The company lowered its revenue outlook for the upcoming quarter and forecast a GAAP EPS loss of $(0.12) to $(0.14) for Q2.
- Technical signals reflect sustained bearish momentum with the stock trading under key moving averages and an expected near-term price range of $9.78 to $10.91.
Revenue and margin forecasts cut as outlook sours
Adtran Holdings, Inc. announced preliminary unaudited financial results for the second quarter of 2026, projecting revenue between $280 million and $282 million, which falls short of previous guidance and the analyst consensus. The preliminary non-GAAP operating margin is estimated at 3.5% to 4.0%, below the earlier guidance of 5% to 9%. The company also reduced its revenue outlook for the upcoming quarter and anticipates a GAAP basic and diluted loss per common share between $(0.12) and $(0.14), accompanied by a lowered revenue forecast for Q3.
Persistent seller control as technical signals show mixed exhaustion
Adtran is trading below its 20-day, 50-day, and 200-day moving averages at $12.96, $14.65, and $11.54, respectively, indicating persistent pressure from sellers across all time frames. The near-term ceiling for the stock is set at $10.3, with support observed at $9.78. While the longer-term trend structure remains bullish based on the alignment of the 50-day against the 200-day average, short-term momentum readings are negative. The MACD and RSI both signal a sell bias, the ADX reads neutral, and the CCI is also in sell territory. The BBP value is negative, confirming intraday selling dominance with an oversold outlook. The stock shows oversold conditions on both RSI and CCI, while the Stochastic RSI indicates strong buy conditions. Adtran fell $1.92, opening with a downside gap of about $2.4, and is currently near the high of its intraday range. Intraday volatility stands at 10.04%. This sharp decline, combined with conflicting signals from momentum and oscillators, indicates ongoing pressure but suggests seller exhaustion may be emerging.
Earlier, analysts noted that Adtran was struggling with technical selling pressure and prevailing bearish momentum. The latest fundamental deterioration and persistent oversold signals reinforce the downside risk, making the $9.78 level critical for gauging whether further weakness will unfold in the near term.